Literature DB >> 29125266

Decision making in very severe traumatic brain injury (Glasgow Coma Scale 3-5): a literature review of acute neurosurgical management.

Jeroen T van Dijck1,2, Florence C Reith3, Inge A van Erp4,5, Thomas A van Essen4,5, Andrew I Maas3, Wilco C Peul4,5, Godard C de Ruiter4,5.   

Abstract

INTRODUCTION: Patients presenting with an early Glasgow Coma Scale (GCS) Score of 3-5 after blunt or penetrating skull-brain assaults are categorized as having sustained a very severe traumatic brain injury (vs-TBI). This category is often overlooked in literature. Impact on patients and families lives however is huge and the question "whether to surgically treat or not" frequently poses a dilemma to treating physicians. Little is known about mortality and outcome, compared to what is known for the group of severe TBI patients (s-TBI) (GCS 3-8). The main goal of this review was creating more awareness for the neurosurgical treatment of this patient group. EVIDENCE ACQUISITION: A literature search (2000-2017) was conducted discussing "severe TBI (GCS 3-8)", "(neuro)surgical management" and "outcome". Ultimately 45 out of 2568 articles were included for further analysis. EVIDENCE SYNTHESIS: Mortality rates and unfavorable outcome are high for s-TBI patients and as expected higher for vs-TBI patients. Mortality rates reach up to 100% for specific subgroups with GCS=3 and bilaterally fixed dilated pupils. Functional outcome was generally poor, but sometimes, although seldom, favorable in specific groups of vs-TBI patients after neurosurgical intervention. Factors like initial GCS, pupillary abnormalities and age seem to be associated with worse outcome.
CONCLUSIONS: Overall this literature review showed high rates of unfavorable outcome and mortality for vs-TBI patients. However, some studies, reporting relatively low mortality rates, reported "good" outcome for specific groups of vs-TBI patients. It is concluded that clinical decision making, in particular those on treatment limitations, should never be taken based on the GCS alone.

Entities:  

Mesh:

Year:  2017        PMID: 29125266     DOI: 10.23736/S0390-5616.17.04255-2

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  5 in total

1.  Current Status and Outcomes of Critical Traumatic Brain Injury (GCS = 3-5) in a Developing Country: A Retrospective, Registry-Based Study.

Authors:  Roham Borazjani; Mohammad Reza Ajdari; Amin Niakan; Omid Yousefi; Arsham Amoozandeh; Mehrab Sayadi; Hosseinali Khalili
Journal:  World J Surg       Date:  2022-07-04       Impact factor: 3.282

2.  Functional and patient-reported outcome versus in-hospital costs after traumatic acute subdural hematoma (t-ASDH): a neurosurgical paradox?

Authors:  Jeroen T J M van Dijck; Thomas A van Essen; Mark D Dijkman; Cassidy Q B Mostert; Suzanne Polinder; Wilco C Peul; Godard C W de Ruiter
Journal:  Acta Neurochir (Wien)       Date:  2019-03-28       Impact factor: 2.216

3.  Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.

Authors:  Inge A M van Erp; Thomas A van Essen; Kees Fluiter; Erik van Zwet; Peter van Vliet; Frank Baas; Iain Haitsma; Dagmar Verbaan; Bert Coert; Godard C W de Ruiter; Wouter A Moojen; Mathieu van der Jagt; Wilco C Peul
Journal:  Trials       Date:  2021-12-04       Impact factor: 2.279

4.  Randomized Evaluation of Surgery in Elderly with Traumatic Acute SubDural Hematoma (RESET-ASDH trial): study protocol for a pragmatic randomized controlled trial with multicenter parallel group design.

Authors:  Jeroen T J M van Dijck; Thomas A van Essen; Ranjit D Singh; Hester F Lingsma; Suzanne S Polinder; Erwin J O Kompanje; Erik W van Zwet; Ewout W Steyerberg; Godard C W de Ruiter; Bart Depreitere; Wilco C Peul
Journal:  Trials       Date:  2022-03-29       Impact factor: 2.279

5.  Functional outcome, in-hospital healthcare consumption and in-hospital costs for hospitalised traumatic brain injury patients: a Dutch prospective multicentre study.

Authors:  Jeroen T J M van Dijck; Cassidy Q B Mostert; Alexander P A Greeven; Erwin J O Kompanje; Wilco C Peul; Godard C W de Ruiter; Suzanne Polinder
Journal:  Acta Neurochir (Wien)       Date:  2020-05-14       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.